You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lucentis

Showing 1 - 25 of 464
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial in Beijing (TAB014 Monoclonal Antibody Injection, Ranibizumab Injection

Recruiting
  • Neovascular Age-related Macular Degeneration
  • TAB014 Monoclonal Antibody Injection
  • Ranibizumab Injection [Lucentis]
  • Beijing, China
    Peking Union Medical College Hospital
Jul 18, 2022

Lucentis® in Patients With Retinopathy of Prematurity

Not yet recruiting
  • Retinopathy of Prematurity
  • Lucentis
  • (no location specified)
Jun 28, 2022

Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration
  • BAT5906 injection
  • Lucentis
  • (no location specified)
Jun 26, 2022

Wet Age-related Macular Degeneration Trial in Beijing, Wuhan, Shanghai (CMAB818, Lucentis®)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
  • +3 more
Jun 14, 2022

Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of

Recruiting
  • Retinopathy of Prematurity
  • Ranibizumab
  • Chengdu, Sichuan, China
  • +2 more
Jan 25, 2023

Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

Withdrawn
  • Wet Macular Degeneration
  • Aflibercept 40 MG/ML [Eylea]
  • +2 more
  • Prague, Czechia
    Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022

naïve Age-related Macular Degeneration Neovascular Type and

Completed
  • Macular Degeneration
  • Data extraction from medical files
  • Brussels, Belgium
    CHU Brugmann
Mar 7, 2022

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Diabetic Macular Edema Trial in Ciudad de Mexico (Bevacizumab, Lucentis®)

Recruiting
  • Diabetic Macular Edema
  • Bevacizumab
  • Lucentis®
  • Bogotá, Colombia
  • +1 more
Aug 31, 2022

Diabetic Macular Edema Trial in Giza (Lucentis alone group, Lucentis dexamethasone group)

Completed
  • Diabetic Macular Edema
  • Lucentis alone group
  • Lucentis dexamethasone group
  • Giza, Cairo, Egypt
    Khaled G Abueleinen
Feb 27, 2022

Diabetic Retinopathy Trial in Nantong (Ranibizumab Injection [Lucentis], Inner limiting membrane stripping, Dexamethasone

Recruiting
  • Diabetic Retinopathy
  • Ranibizumab Injection [Lucentis]
  • +2 more
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Mar 7, 2022

Age-Related Macular Degeneration Trial in Philippines, United States (2.0 mg DE-122 Injectable Solution + Lucentis, 4.0 mg

Completed
Has Results
  • Age-Related Macular Degeneration
  • 2.0 mg DE-122 Injectable Solution + Lucentis
  • +2 more
  • Gilbert, Arizona
  • +13 more
Jun 22, 2021

Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))

Completed
  • Retina Disease
  • +2 more
  • Ranibizumab (0.25 mg/0.025 mL)
  • Zagazig, Egypt
    Zagazig University, Faculty of medicine
Jan 26, 2023

Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,

Completed
  • Branch Retinal Vein Occlusion
  • +2 more
  • Beijing, Beijing, China
    Beijing Hospital
Dec 25, 2022

Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

Not yet recruiting
  • Exudative Age Related Macular Degeneration
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Nov 28, 2022

Neovascular(Wet) Age Related Macular Degeneration Trial in Seoul (CKD-701, Lucentis®)

Completed
  • Neovascular(Wet) Age Related Macular Degeneration
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 22, 2021

Wet Age-related Macular Degeneration Trial in Chengdu (MW02, Lucentis)

Recruiting
  • Wet Age-related Macular Degeneration
  • Chengdu, Si Chuan, China
    West China Hospital of Sichuan University
Mar 17, 2022

Wet Age-related Macular Degeneration Trial in Hungary, Latvia, United States (Zimura, Lucentis)

Completed
Has Results
  • Wet Age-related Macular Degeneration
  • Phoenix, Arizona
  • +27 more
Feb 3, 2022

Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection

Recruiting
  • Mild Non-proliferative Diabetic Retinopathy
  • +2 more
  • Ranibizumab Injection [Lucentis]
  • Phacoemulsification
  • Shanghai, Shanghai, China
    Department of Ophthalmology, Ruijin Hospital Affiliated Medical,
May 18, 2022

Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

Completed
  • Wet Age-related Macular Degeneration
  • Intravitreal anti-VEGF
  • +2 more
  • Boston, Massachusetts
  • +1 more
May 24, 2022

Reading Speed Improvements in Wet-AMD Patients After Ranibizumab

Completed
  • Ophthalmopathy
  • Wet Macular Degeneration
    • (no location specified)
    Jul 20, 2021

    Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

    Recruiting
    • Diabetic Macular Edema
    • Cataract
    • Walnut Creek, California
      Bay Area Retina Associates
    Mar 1, 2022

    Branch Retinal Vein Occlusion With Macular Edema Trial in Stockholm (Aflibercept Injection [Eylea], Ranibizumab Injection

    Recruiting
    • Branch Retinal Vein Occlusion With Macular Edema
    • Aflibercept Injection [Eylea]
    • Ranibizumab Injection [Lucentis]
    • Stockholm, Sweden
      St Eriks Eye Hospital
    Dec 2, 2020

    Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal

    Recruiting
    • Diabetic Macular Edema
    • +3 more
    • Intravitreal ranibizumab
    • Intravitreal bevacizumab
    • Cairo, Egypt
      Cairo University
    Nov 26, 2021

    Ocular Adverse Events in Neovascular Agerelated Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021